José M. Jimeno-rekin lankidetzan egindako argitalpenak (4)

2005

  1. Ecteinascidin-743 (ET-743) for chemotherapy-naive patients with advanced soft tissue sarcomas: Multicenter phase II and pharmacokinetic study

    Journal of Clinical Oncology, Vol. 23, Núm. 24, pp. 5484-5492

2004

  1. Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy

    Journal of Clinical Oncology, Vol. 22, Núm. 8, pp. 1480-1490

2002

  1. A phase II and pharmacokinetic study of ecteinascidin 743 in patients with gastrointestinal stromal tumors

    Oncologist, Vol. 7, Núm. 6, pp. 531-538

  2. Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: Associations with clinical characteristics, pathophysiological variables and toxicity

    Cancer Chemotherapy and Pharmacology, Vol. 50, Núm. 4, pp. 309-319